intermedical webinar

Carbon Monoxide Breath Testing Beyond Cigarettes: Emerging Evidence and Best Practice in Community and Secondary Care

Tuesday, 3rd February 2026

Speakers
Louise Ross – Clinical Consultant (NCSCT) and Stop Smoking Lead, Smoke Free Digital
Heidi Croucher – Lead Convenor, Smoking Cessation and Harm Reduction (SCaH) and Lead Treating Tobacco Dependency Midwife, NHS England Prevention
Kevin Smith – Harm Reduction Practitioner, Dorset HealthCare

Session Overview

Carbon monoxide (CO) breath testing is widely recognised as a key tool in smoking cessation, but its role is expanding across community, maternity, mental health and secondary care settings. This webinar will explore emerging evidence, practical applications and real-world examples demonstrating how CO breath testing can support wider tobacco dependency treatment and harm reduction pathways.

Topics

Carbon monoxide breath testing in the community | Shisha use and carbon monoxide exposure | Cannabis use and carbon monoxide | Embedding CO breath testing within secondary care as best practice | Case study from a Dorset mental health inpatient hospital | Live Q&A session

Smoking Cessation Services for People with Serious Mental Illness: A rapid evaluation

Tuesday 9th December 2025

Speaker: Dr Jennifer Newbould, Senior Research Leader at RAND Europe and member of the Executive and Co-PPIE Lead for BRACE (The Birmingham, RAND and Cambridge Evaluation Centre, funded by the National Institute for Health and Care Research).

In this webinar, Jennifer presented the BRACE study, a rapid evaluation of NHS England’s stop smoking services for people with severe mental illness (SMI). 

Drawing on a mixed-methods approach, Jennifer presented findings on service delivery, measures of success, and referral pathways, and shared insights from people with lived experience of smoking and SMI. She concluded by offering recommendations for service development, policymakers, and future evaluation.

Dr Jennifer Newbould has over twenty-five years’ experience in health services research. Her work focuses on rapid evaluation, primary care and patient experience. Dr Newbould currently co-leads the Drug Strategy Investment in Treatment And Recovery (D-SITAR) Evaluation (with Ms Lucy Strang, RAND Europe) and the CONCORD: Coordinated Care of Rare Diseases study (with Prof Stephen Morris, University of Cambridge). She is Principle-Investigator on the smoking cessation for people with serious mental illness project.